Literature DB >> 26790921

Clostridium difficile flagella predominantly activate TLR5-linked NF-κB pathway in epithelial cells.

Jameel Batah1, Cécile Denève-Larrazet1, Pierre-Alain Jolivot1, Sarah Kuehne2, Anne Collignon1, Jean-Christophe Marvaud1, Imad Kansau3.   

Abstract

Clostridium difficile has become the most common enteropathogen responsible for intestinal nosocomial post-antibiotic infections. This has coincided with the appearance of serious cases related to the emergence of hypervirulent strains. The toxins are the main virulence factors and elicit an inflammatory response during C. difficile infection. However, other bacterial components appear to be involved in the inflammatory process. In some pathogens, flagella play a role in pathogenesis through abnormal stimulation of the TLR5-mediated host immune response. To date, few studies have addressed this role for C. difficile flagella. In the current study, we confirm in two different epithelial cell models that C. difficile thanks to its FliC flagellin interacts with TLR5. In addition, thanks to inhibition and transcriptomic studies we demonstrate that the interaction of flagellin and TLR5 predominantly activates the NF-κB and, in a lesser degree, the MAPK pathways, via TLR5, leading to up-regulation of pro-inflammatory gene expression and synthesis of pro-inflammatory mediators. These results suggest a role for C. difficile flagella in contributing to inflammatory response in host intestinal cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Flagella; Flagellin; Innate immune response; MAPK; NF-κB; Pro-inflammatory cytokines; TLR5 signaling

Mesh:

Substances:

Year:  2016        PMID: 26790921     DOI: 10.1016/j.anaerobe.2016.01.002

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  13 in total

Review 1.  Understanding Clostridium difficile Colonization.

Authors:  Monique J T Crobach; Jonathan J Vernon; Vivian G Loo; Ling Yuan Kong; Séverine Péchiné; Mark H Wilcox; Ed J Kuijper
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

2.  Clostridium difficile toxin B-induced colonic inflammation is mediated by the FOXO3/PPM1B pathway in fetal human colon epithelial cells.

Authors:  Qingqing Xu; Ying Li; Yuejuan Zheng; Yijian Chen; Xiaogang Xu; Minggui Wang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Ethanolamine is a valuable nutrient source that impacts Clostridium difficile pathogenesis.

Authors:  Kathryn L Nawrocki; Daniela Wetzel; Joshua B Jones; Emily C Woods; Shonna M McBride
Journal:  Environ Microbiol       Date:  2018-02-09       Impact factor: 5.491

4.  Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.

Authors:  Jean-François Bruxelle; Assaf Mizrahi; Sandra Hoÿs; Anne Collignon; Claire Janoir; Séverine Péchiné
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

5.  Clostridium difficile flagella induce a pro-inflammatory response in intestinal epithelium of mice in cooperation with toxins.

Authors:  Jameel Batah; Hussein Kobeissy; Phuong Trang Bui Pham; Cécile Denève-Larrazet; Sarah Kuehne; Anne Collignon; Claire Janoir-Jouveshomme; Jean-Christophe Marvaud; Imad Kansau
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

6.  A genetic switch controls the production of flagella and toxins in Clostridium difficile.

Authors:  Brandon R Anjuwon-Foster; Rita Tamayo
Journal:  PLoS Genet       Date:  2017-03-27       Impact factor: 5.917

7.  Role of Glycosyltransferases Modifying Type B Flagellin of Emerging Hypervirulent Clostridium difficile Lineages and Their Impact on Motility and Biofilm Formation.

Authors:  Esmeralda Valiente; Laura Bouché; Paul Hitchen; Alexandra Faulds-Pain; Mario Songane; Lisa F Dawson; Elizabeth Donahue; Richard A Stabler; Maria Panico; Howard R Morris; Mona Bajaj-Elliott; Susan M Logan; Anne Dell; Brendan W Wren
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

Review 8.  Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection.

Authors:  Séverine Péchiné; Jean F Bruxelle; Claire Janoir; Anne Collignon
Journal:  Front Microbiol       Date:  2018-05-23       Impact factor: 5.640

Review 9.  Phase variation of Clostridium difficile virulence factors.

Authors:  Brandon R Anjuwon-Foster; Rita Tamayo
Journal:  Gut Microbes       Date:  2017-09-21

10.  In silico designing of vaccine candidate against Clostridium difficile.

Authors:  Srijita Basak; Debashrito Deb; Utkarsh Narsaria; Tamalika Kar; Filippo Castiglione; Indraneel Sanyal; Pratap D Bade; Anurag P Srivastava
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.